{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:02:11Z","timestamp":1789552931286,"version":"build-2803163510"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM147484"],"award-info":[{"award-number":["R35GM147484"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001797","name":"Pharmaceutical Research and Manufacturers of America Foundation","doi-asserted-by":"publisher","award":["PFDL23 1003168"],"award-info":[{"award-number":["PFDL23 1003168"]}],"id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"DOI":"10.1038\/s41564-026-02484-3","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:02:57Z","timestamp":1789549377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prophage-encoding engineered bacteria enable prophylactic lytic phage therapy for enteric infection in mice"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4987-1168","authenticated-orcid":false,"given":"Rogerio A.","family":"Bataglioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Baaziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hallie F.","family":"Avalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary R.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita J.","family":"Makhlouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1958-8409","authenticated-orcid":false,"given":"David","family":"da Silva Barreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsimran","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Southard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8219-1124","authenticated-orcid":false,"given":"Bryan B.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"2484_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110649","volume":"39","author":"WE Anthony","year":"2022","unstructured":"Anthony, W. E. et al. Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults. Cell Rep. 39, 110649 (2022).","journal-title":"Cell Rep."},{"key":"2484_CR2","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.1016\/j.cell.2024.09.009","volume":"187","author":"M Koncz","year":"2024","unstructured":"Koncz, M. et al. Genomic surveillance as a scalable framework for precision phage therapy against antibiotic-resistant pathogens. Cell 187, 5901\u20135918 (2024).","journal-title":"Cell"},{"key":"2484_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/1471-2180-13-202","volume":"13","author":"BW Brunelle","year":"2013","unstructured":"Brunelle, B. W., Bearson, S. M. & Bearson, B. L. Tetracycline accelerates the temporally-regulated invasion response in specific isolates of multidrug-resistant Salmonella enterica serovar Typhimurium. BMC Microbiol. 13, 202 (2013).","journal-title":"BMC Microbiol."},{"key":"2484_CR4","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41564-024-01705-x","volume":"9","author":"J-P Pirnay","year":"2024","unstructured":"Pirnay, J.-P. et al. Bacteriophage therapy providers, bacteriophage donors, personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study. Nat. Microbiol. 9, 1434\u20131453 (2024).","journal-title":"Nat. Microbiol."},{"key":"2484_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13567-021-00991-1","volume":"52","author":"H Yin","year":"2021","unstructured":"Yin, H. et al. Microencapsulated phages show prolonged stability in gastrointestinal environments and high therapeutic efficiency to treat Escherichia coli O157:H7 infection. Vet. Res. 52, 118 (2021).","journal-title":"Vet. Res."},{"key":"2484_CR6","first-page":"e00232","volume":"10","author":"W Yuxin","year":"2022","unstructured":"Yuxin, W. et al. Phage cocktail targeting STEC O157:H7 has comparable efficacy and superior recovery compared with enrofloxacin in an enteric murine model. Microbiol. Spectr. 10, e00232\u201322 (2022).","journal-title":"Microbiol. Spectr."},{"key":"2484_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14187","volume":"8","author":"M Yen","year":"2017","unstructured":"Yen, M., Cairns, L. S. & Camilli, A. A cocktail of three virulent bacteriophages prevents Vibrio cholerae infection in animal models. Nat. Commun. 8, 14187 (2017).","journal-title":"Nat. Commun."},{"key":"2484_CR8","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12866-023-03040-3","volume":"23","author":"P Mondal","year":"2023","unstructured":"Mondal, P. et al. Controlling the bacterial load of Salmonella Typhi in an experimental mouse model by a lytic Salmonella phage STWB21: a phage therapy approach. BMC Microbiol. 23, 324 (2023).","journal-title":"BMC Microbiol."},{"key":"2484_CR9","doi-asserted-by":"publisher","first-page":"955136","DOI":"10.3389\/fmicb.2022.955136","volume":"13","author":"C Sukjoi","year":"2022","unstructured":"Sukjoi, C. et al. Therapeutic effects of oral administration of lytic Salmonella phages in a mouse model of non-typhoidal salmonellosis. Front. Microbiol. 13, 955136 (2022).","journal-title":"Front. Microbiol."},{"key":"2484_CR10","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1128\/AEM.00812-15","volume":"81","author":"C Joan","year":"2015","unstructured":"Joan, C. et al. Liposome-encapsulated bacteriophages for enhanced oral phage therapy against Salmonella spp. Appl. Environ. Microbiol. 81, 4841\u20134849 (2015).","journal-title":"Appl. Environ. Microbiol."},{"key":"2484_CR11","doi-asserted-by":"publisher","first-page":"5054","DOI":"10.3382\/ps\/pez251","volume":"98","author":"V Clavijo","year":"2019","unstructured":"Clavijo, V. et al. Phage cocktail SalmoFREE\u00ae reduces Salmonella on a commercial broiler farm. Poult. Sci. 98, 5054\u20135063 (2019).","journal-title":"Poult. Sci."},{"key":"2484_CR12","doi-asserted-by":"publisher","first-page":"2217947","DOI":"10.1080\/22221751.2023.2217947","volume":"12","author":"AM Thanki","year":"2023","unstructured":"Thanki, A. M. et al. A bacteriophage cocktail delivered in feed significantly reduced Salmonella colonization in challenged broiler chickens. Emerg. Microbes Infect. 12, 2217947 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"2484_CR13","first-page":"e04296","volume":"11","author":"N Marianne","year":"2023","unstructured":"Marianne, N. et al. Isolation and characterization of a novel phage collection against avian-pathogenic Escherichia coli. Microbiol. Spectr. 11, e04296\u201322 (2023).","journal-title":"Microbiol. Spectr."},{"key":"2484_CR14","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3389\/fmicb.2020.00632","volume":"11","author":"HN Chinivasagam","year":"2020","unstructured":"Chinivasagam, H. N. et al. Bacteriophages to control campylobacter in commercially farmed broiler chickens, in Australia. Front. Microbiol. 11, 632 (2020).","journal-title":"Front. Microbiol."},{"key":"2484_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1006\/anae.1999.0192","volume":"5","author":"V Ramesh","year":"1999","unstructured":"Ramesh, V., Fralick, J. A. & Rolfe, R. D. Prevention of Clostridium difficile-induced ileocecitis with bacteriophage. Anaerobe 5, 69\u201378 (1999).","journal-title":"Anaerobe"},{"key":"2484_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39028-w","volume":"14","author":"L Gan","year":"2023","unstructured":"Gan, L. et al. Bacteriophage targeting microbiota alleviates non-alcoholic fatty liver disease induced by high alcohol-producing Klebsiella pneumoniae. Nat. Commun. 14, 3215 (2023).","journal-title":"Nat. Commun."},{"key":"2484_CR17","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/nbt.3043","volume":"32","author":"D Bikard","year":"2014","unstructured":"Bikard, D. et al. Exploiting CRISPR\u2013Cas nucleases to produce sequence-specific antimicrobials. Nat. Biotechnol. 32, 1146 (2014).","journal-title":"Nat. Biotechnol."},{"key":"2484_CR18","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/nbt.3011","volume":"32","author":"RJ Citorik","year":"2014","unstructured":"Citorik, R. J., Mimee, M. & Lu, T. K. Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat. Biotechnol. 32, 1141\u20131145 (2014).","journal-title":"Nat. Biotechnol."},{"key":"2484_CR19","first-page":"e00019","volume":"11","author":"S Kurt","year":"2020","unstructured":"Kurt, S. et al. In vivo targeting of clostridioides difficile using phage-delivered CRISPR\u2013Cas3 antimicrobials. mBio 11, e00019\u201320 (2020).","journal-title":"mBio"},{"key":"2484_CR20","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41586-024-07681-w","volume":"632","author":"AK Br\u00f6del","year":"2024","unstructured":"Br\u00f6del, A. K. et al. In situ targeted base editing of bacteria in the mouse gut. Nature 632, 877\u2013884 (2024).","journal-title":"Nature"},{"key":"2484_CR21","doi-asserted-by":"publisher","first-page":"e00013","DOI":"10.1128\/msystems.00013-20","volume":"5","author":"BB Hsu","year":"2020","unstructured":"Hsu, B. B., Way, J. C. & Silver, P. A. Stable neutralization of a virulence factor in bacteria using temperate phage in the mammalian gut. mSystems 5, e00013\u2013e00020 (2020).","journal-title":"mSystems"},{"key":"2484_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18614-2","volume":"11","author":"BB Hsu","year":"2020","unstructured":"Hsu, B. B. et al. In situ reprogramming of gut bacteria by oral delivery. Nat. Commun. 11, 5030 (2020).","journal-title":"Nat. Commun."},{"key":"2484_CR23","first-page":"e01341","volume":"70","author":"BE Maosa","year":"2025","unstructured":"Maosa, B. E. et al. A recombinant lysogenic bacteriophage inhibits Salmonella virulence. Antimicrob. Agents Chemother. 70, e01341\u201325 (2025).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2484_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-025-02570-7","author":"ZR Baker","year":"2025","unstructured":"Baker, Z. R. et al. Sustained in situ protein production and release in the mammalian gut by an engineered bacteriophage. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-025-02570-7 (2025).","journal-title":"Nat. Biotechnol."},{"key":"2484_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15508-1","volume":"11","author":"MR Charbonneau","year":"2020","unstructured":"Charbonneau, M. R., Isabella, V. M., Li, N. & Kurtz, C. B. Developing a new class of engineered live bacterial therapeutics to treat human diseases. Nat. Commun. 11, 1738 (2020.","journal-title":"Nat. Commun."},{"key":"2484_CR26","doi-asserted-by":"publisher","first-page":"5032","DOI":"10.1128\/AEM.69.8.5032-5036.2003","volume":"69","author":"D Goode","year":"2003","unstructured":"Goode, D., Allen, V. M. & Barrow, P. A. Reduction of experimental Salmonella and Campylobacter contamination of chicken skin by application of lytic bacteriophages. Appl. Environ. Microbiol. 69, 5032\u20135036 (2003).","journal-title":"Appl. Environ. Microbiol."},{"key":"2484_CR27","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.chom.2020.06.002","volume":"28","author":"M Louren\u00e7o","year":"2020","unstructured":"Louren\u00e7o, M. et al. The spatial heterogeneity of the gut limits predation and fosters coexistence of bacteria and bacteriophages. Cell Host Microbe 28, 390\u2013401 (2020).","journal-title":"Cell Host Microbe"},{"key":"2484_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2019.01.017","volume":"25","author":"AN Shkoporov","year":"2019","unstructured":"Shkoporov, A. N. & Hill, C. Bacteriophages of the human gut: the \u2018known unknown\u2019 of the microbiome. Cell Host Microbe 25, 195\u2013209 (2019).","journal-title":"Cell Host Microbe"},{"key":"2484_CR29","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1128\/AAC.01774-15","volume":"60","author":"JY Nale","year":"2016","unstructured":"Nale, J. Y. et al. Bacteriophage combinations significantly reduce Clostridium difficile growth in vitro and proliferation in vivo. Antimicrob. Agents Chemother. 60, 968\u2013981 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2484_CR30","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.4315\/0362-028X.JFP-11-417","volume":"75","author":"S Hoffmann","year":"2012","unstructured":"Hoffmann, S., Batz, M. B. & Morris, J. G. Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens J. Food Prot. 75, 1292\u20131302 (2012).","journal-title":"J. Food Prot."},{"key":"2484_CR31","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1086\/649878","volume":"50","author":"MD Kirk","year":"2010","unstructured":"Kirk, M. D., Veitch, M. G. & Hall, G. V. Gastroenteritis and food-borne disease in elderly people living in long-term care. Clin. Infect. Dis. 50, 397\u2013404 (2010).","journal-title":"Clin. Infect. Dis."},{"key":"2484_CR32","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/S1473-3099(19)30418-9","volume":"19","author":"JD Stanaway","year":"2019","unstructured":"Stanaway, J. D. et al. The global burden of non-typhoidal Salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Infect. Dis. 19, 1312\u20131324 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"2484_CR33","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1080\/21553769.2015.1051243","volume":"8","author":"S-K Eng","year":"2015","unstructured":"Eng, S.-K. et al. Salmonella: a review on pathogenesis, epidemiology and antibiotic resistance. Front. Life Sci. 8, 284\u2013293 (2015).","journal-title":"Front. Life Sci."},{"key":"2484_CR34","doi-asserted-by":"publisher","first-page":"100940","DOI":"10.1016\/j.lanmic.2024.07.003","volume":"5","author":"T Jesudason","year":"2024","unstructured":"Jesudason, T. WHO publishes updated list of bacterial priority pathogens. Lancet Microbe 5, 100940 (2024).","journal-title":"Lancet Microbe"},{"key":"2484_CR35","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1017\/S095026881000292X","volume":"139","author":"Y Hara-Kudo","year":"2011","unstructured":"Hara-Kudo, Y. & Takatori, K. Contamination level and ingestion dose of foodborne pathogens associated with infections. Epidemiol. Infect. 139, 1505\u20131510 (2011).","journal-title":"Epidemiol. Infect."},{"key":"2484_CR36","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.3201\/eid2608.200346","volume":"26","author":"GW Park","year":"2020","unstructured":"Park, G. W. et al. CrAssphage as a novel tool to detect human fecal contamination on environmental surfaces and hands. Emerg. Infect. Dis. J. 26, 1731 (2020).","journal-title":"Emerg. Infect. Dis. J."},{"key":"2484_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.virol.2009.07.020","volume":"393","author":"M Weiss","year":"2009","unstructured":"Weiss, M. et al. In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli. Virology 393, 16\u201323 (2009).","journal-title":"Virology"},{"key":"2484_CR38","first-page":"e00120","volume":"11","author":"F Mike","year":"2022","unstructured":"Mike, F. et al. Complete genome sequences of lambdoid phages 21, 434, and 434B and several lambda hybrids. Microbiol. Resour. Announc. 11, e00120\u2013e00122 (2022).","journal-title":"Microbiol. Resour. Announc."},{"key":"2484_CR39","doi-asserted-by":"publisher","first-page":"7115","DOI":"10.1128\/jb.175.21.7115-7118.1993","volume":"175","author":"BL Neal","year":"1993","unstructured":"Neal, B. L., Brown, P. K. & Reeves, P. R. Use of Salmonella phage P22 for transduction in Escherichia coli. J. Bacteriol. 175, 7115\u20137118 (1993).","journal-title":"J. Bacteriol."},{"key":"2484_CR40","doi-asserted-by":"publisher","first-page":"109595","DOI":"10.1016\/j.isci.2024.109595","volume":"27","author":"H Baaziz","year":"2024","unstructured":"Baaziz, H., Makhlouf, R., McClelland, M. & Hsu, B. B. Bacterial resistance to temperate phage is influenced by the frequency of lysogenic establishment. iScience 27, 109595 (2024).","journal-title":"iScience"},{"key":"2484_CR41","doi-asserted-by":"publisher","first-page":"e1003269","DOI":"10.1371\/journal.pgen.1003269","volume":"9","author":"W Cenens","year":"2013","unstructured":"Cenens, W. et al. Expression of a novel P22 ORFan gene reveals the phage carrier state in Salmonella typhimurium. PLoS Genet. 9, e1003269 (2013).","journal-title":"PLoS Genet."},{"key":"2484_CR42","doi-asserted-by":"publisher","first-page":"e02085","DOI":"10.1128\/mbio.02085-21","volume":"13","author":"K Pick","year":"2022","unstructured":"Pick, K., Ju, T., Willing, B. P. & Raivio, T. L. Isolation and characterization of a novel temperate Escherichia coli bacteriophage, Kapi1, which modifies the O-antigen and contributes to the competitiveness of its host during colonization of the murine gastrointestinal tract. mBio 13, e02085\u201321 (2022).","journal-title":"mBio"},{"key":"2484_CR43","doi-asserted-by":"publisher","first-page":"6640","DOI":"10.1073\/pnas.120163297","volume":"97","author":"KA Datsenko","year":"2000","unstructured":"Datsenko, K. A. & Wanner, B. L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl Acad. Sci. USA 97, 6640 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2484_CR44","doi-asserted-by":"publisher","first-page":"e0123639","DOI":"10.1371\/journal.pone.0123639","volume":"10","author":"C Pirone-Davies","year":"2015","unstructured":"Pirone-Davies, C. et al. Genome-wide methylation patterns in Salmonella enterica Subsp. enterica serovars. PLoS ONE 10, e0123639 (2015).","journal-title":"PLoS ONE"},{"key":"2484_CR45","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1128\/jb.173.3.1328-1330.1991","volume":"173","author":"O De Backer","year":"1991","unstructured":"De Backer, O. & Colson, C. Transfer of the genes for the StyLTI restriction\u2013modification system of Salmonella typhimurium to strains lacking modification ability results in death of the recipient cells and degradation of their DNA. J. Bacteriol. 173, 1328\u20131330 (1991).","journal-title":"J. Bacteriol."},{"key":"2484_CR46","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1099\/00221287-135-9-2561","volume":"135","author":"SP Tsai","year":"1989","unstructured":"Tsai, S. P., Hartin, R. J. & Ryu, J.-I. Transformation in restriction-deficient Salmonella typhimurium LT2. Microbiology 135, 2561\u20132567 (1989).","journal-title":"Microbiology"},{"key":"2484_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009943","volume":"18","author":"J Zaworski","year":"2022","unstructured":"Zaworski, J. et al. Reassembling a cannon in the DNA defense arsenal: genetics of StySA, a BREX phage exclusion system in Salmonella lab strains. PLoS Genet. 18, e1009943 (2022).","journal-title":"PLoS Genet."},{"key":"2484_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13036-017-0075-2","volume":"11","author":"Q Yan","year":"2017","unstructured":"Yan, Q. & Fong, S. S. Study of in vitro transcriptional binding effects and noise using constitutive promoters combined with UP element sequences in Escherichia coli. J. Biol. Eng. 11, 33 (2017).","journal-title":"J. Biol. Eng."},{"key":"2484_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32829-5","volume":"13","author":"TL LaFleur","year":"2022","unstructured":"LaFleur, T. L., Hossain, A. & Salis, H. M. Automated model-predictive design of synthetic promoters to control transcriptional profiles in bacteria. Nat. Commun. 13, 5159 (2022).","journal-title":"Nat. Commun."},{"key":"2484_CR50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/294217a0","volume":"294","author":"AD Johnson","year":"1981","unstructured":"Johnson, A. D. et al. \u03bb Repressor and cro\u2014components of an efficient molecular switch. Nature 294, 217\u2013223 (1981).","journal-title":"Nature"},{"key":"2484_CR51","doi-asserted-by":"publisher","first-page":"20705","DOI":"10.1073\/pnas.0808831105","volume":"105","author":"F St-Pierre","year":"2008","unstructured":"St-Pierre, F. & Endy, D. Determination of cell fate selection during phage lambda infection. Proc. Natl Acad. Sci. USA 105, 20705\u201320710 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2484_CR52","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/genetics\/149.4.1633","volume":"149","author":"A Arkin","year":"1998","unstructured":"Arkin, A., Ross, J. & McAdams, H. H. Stochastic Kinetic analysis of developmental pathway bifurcation in phage \u03bb-infected Escherichia coli cells. Genetics 149, 1633\u20131648 (1998).","journal-title":"Genetics"},{"key":"2484_CR53","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/0042-6822(57)90021-1","volume":"3","author":"M Levine","year":"1957","unstructured":"Levine, M. Mutations in the temperate phage P22 and lysogeny in Salmonella. Virology 3, 22\u201341 (1957).","journal-title":"Virology"},{"key":"2484_CR54","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1128\/mr.42.2.385-413.1978","volume":"42","author":"MM Susskind","year":"1978","unstructured":"Susskind, M. M. & Botstein, D. Molecular genetics of bacteriophage P22. Microbiol. Rev. 42, 385\u2013413 (1978).","journal-title":"Microbiol. Rev."},{"key":"2484_CR55","doi-asserted-by":"publisher","first-page":"001126","DOI":"10.1099\/mic.0.001126","volume":"167","author":"BA Adler","year":"2021","unstructured":"Adler, B. A. et al. The genetic basis of phage susceptibility, cross-resistance and host-range in Salmonella. Microbiology 167, 001126 (2021).","journal-title":"Microbiology"},{"key":"2484_CR56","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1086\/318457","volume":"32","author":"D Acheson","year":"2001","unstructured":"Acheson, D. & Hohmann, E. L. Nontyphoidal salmonellosis. Clin. Infect. Dis. 32, 263\u2013269 (2001).","journal-title":"Clin. Infect. Dis."},{"key":"2484_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.824","volume":"3","author":"GT Walker","year":"2023","unstructured":"Walker, G. T., Gerner, R. R., Nuccio, S.-P. & Raffatellu, M. Murine models of Salmonella infection. Curr. Protoc. 3, e824 (2023).","journal-title":"Curr. Protoc."},{"key":"2484_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2022.102224","volume":"70","author":"JP Newson","year":"2022","unstructured":"Newson, J. P., Gaissmaier, M. S., McHugh, S. C. & Hardt, W.-D. Studying antibiotic persistence in vivo using the model organism Salmonella Typhimurium. Curr. Opin. Microbiol. 70, 102224 (2022).","journal-title":"Curr. Opin. Microbiol."},{"key":"2484_CR59","doi-asserted-by":"publisher","first-page":"8039","DOI":"10.1128\/IAI.73.12.8039-8049.2005","volume":"73","author":"MP Leatham","year":"2005","unstructured":"Leatham, M. P. et al. Mouse intestine selects nonmotile flhDC mutants of Escherichia coli MG1655 with increased colonizing ability and better utilization of carbon sources. Infect. Immun. 73, 8039\u20138049 (2005).","journal-title":"Infect. Immun."},{"key":"2484_CR60","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1128\/iai.64.9.3497-3503.1996","volume":"64","author":"NJ Sweeney","year":"1996","unstructured":"Sweeney, N. J. et al. The Escherichia coli K-12 gntP gene allows E. coli F-18 to occupy a distinct nutritional niche in the streptomycin-treated mouse large intestine. Infect. Immun. 64, 3497\u20133503 (1996).","journal-title":"Infect. Immun."},{"key":"2484_CR61","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1128\/IAI.71.5.2839-2858.2003","volume":"71","author":"M Barthel","year":"2003","unstructured":"Barthel, M. et al. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect. Immun. 71, 2839\u20132858 (2003).","journal-title":"Infect. Immun."},{"key":"2484_CR62","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1093\/clinids\/4.6.1096","volume":"4","author":"MJ Blaser","year":"1982","unstructured":"Blaser, M. J. & Newman, L. S. A review of human salmonellosis: I. Infective dose. Rev. Infect. Dis. 4, 1096\u20131106 (1982).","journal-title":"Rev. Infect. Dis."},{"key":"2484_CR63","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ijfoodmicro.2010.09.026","volume":"144","author":"PFM Teunis","year":"2010","unstructured":"Teunis, P. F. M. et al. Dose\u2013response modeling of Salmonella using outbreak data. Int. J. Food Microbiol. 144, 243\u2013249 (2010).","journal-title":"Int. J. Food Microbiol."},{"key":"2484_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36162-3","volume":"14","author":"IW Campbell","year":"2023","unstructured":"Campbell, I. W., Hullahalli, K., Turner, J. R. & Waldor, M. K. Quantitative dose-response analysis untangles host bottlenecks to enteric infection. Nat. Commun. 14, 456 (2023).","journal-title":"Nat. Commun."},{"key":"2484_CR65","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41579-022-00833-7","volume":"21","author":"G Caballero-Flores","year":"2023","unstructured":"Caballero-Flores, G., Pickard, J. M. & N\u00fa\u00f1ez, G. Microbiota-mediated colonization resistance: mechanisms and regulation. Nat. Rev. Microbiol. 21, 347\u2013360 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"2484_CR66","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.101388.3","volume":"13","author":"JA Hotinger","year":"2025","unstructured":"Hotinger, J. A., Campbell, I. W., Hullahalli, K., Osaki, A. & Waldor, M. K. Quantification of Salmonella enterica serovar Typhimurium population dynamics in murine infection using a highly diverse barcoded library. eLife 13, RP101388 (2025).","journal-title":"eLife"},{"key":"2484_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/ecosalplus.8.6.2.2","volume":"5","author":"GC Langridge","year":"2012","unstructured":"Langridge, G. C., Wain, J. & Nair, S. Invasive salmonellosis in humans. EcoSal Plus 5, 1\u201314 (2012).","journal-title":"EcoSal Plus"},{"key":"2484_CR68","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.chom.2021.04.017","volume":"29","author":"A Chong","year":"2021","unstructured":"Chong, A. et al. Cytosolic replication in epithelial cells fuels intestinal expansion and chronic fecal shedding of Salmonella Typhimurium. Cell Host Microbe 29, 1177\u20131185 (2021).","journal-title":"Cell Host Microbe"},{"key":"2484_CR69","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.69744","volume":"10","author":"E Bakkeren","year":"2021","unstructured":"Bakkeren, E. et al. Pathogen invasion-dependent tissue reservoirs and plasmid-encoded antibiotic degradation boost plasmid spread in the gut. eLife 10, e69744 (2021).","journal-title":"eLife"},{"key":"2484_CR70","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.tim.2018.10.008","volume":"27","author":"R Monteiro","year":"2019","unstructured":"Monteiro, R., Pires, D. P., Costa, A. R. & Azeredo, J. Phage therapy: going temperate? Trends Microbiol. 27, 368\u2013378 (2019).","journal-title":"Trends Microbiol."},{"key":"2484_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49710-2","volume":"15","author":"F Bayat","year":"2024","unstructured":"Bayat, F. et al. High throughput platform technology for rapid target identification in personalized phage therapy. Nat. Commun. 15, 5626 (2024).","journal-title":"Nat. Commun."},{"key":"2484_CR72","doi-asserted-by":"publisher","first-page":"e0262946","DOI":"10.1371\/journal.pone.0262946","volume":"17","author":"Z Sun","year":"2022","unstructured":"Sun, Z., Mandlaa, Wen, H., Ma, L. & Chen, Z. Isolation, characterization and application of bacteriophage PSDA-2 against Salmonella Typhimurium in chilled mutton. PLoS ONE 17, e0262946 (2022).","journal-title":"PLoS ONE"},{"key":"2484_CR73","unstructured":"Ptashne, M. A Genetic Switch: Phage Lambda Revisited 3rd edn (Cold Spring Harbor Laboratory Press, 2004)."},{"key":"2484_CR74","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1073\/pnas.72.1.147","volume":"72","author":"JW Roberts","year":"1975","unstructured":"Roberts, J. W. & Roberts, C. W. Proteolytic cleavage of bacteriophage lambda repressor in induction. Proc. Natl Acad. Sci. USA 72, 147\u2013151 (1975).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2484_CR75","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1101\/gr.280248.124","volume":"35","author":"C Zheng","year":"2025","unstructured":"Zheng, C., Casjens, S. R., Davidson, A. R., Amundsen, S. K. & Smith, G. R. Lambdoid phages with abundant Chi recombination hotspots reflect diverse viral strategies for recombination-dependent growth. Genome Res. 35, 1767\u20131780 (2025).","journal-title":"Genome Res."},{"key":"2484_CR76","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.cell.2025.01.038","volume":"188","author":"S Turjeman","year":"2025","unstructured":"Turjeman, S., Rozera, T., Elinav, E., Ianiro, G. & Koren, O. From big data and experimental models to clinical trials: iterative strategies in microbiome research. Cell 188, 1178\u20131197 (2025).","journal-title":"Cell"},{"key":"2484_CR77","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.chom.2021.12.003","volume":"30","author":"BS Beresford-Jones","year":"2022","unstructured":"Beresford-Jones, B. S. et al. The Mouse Gastrointestinal Bacteria Catalogue enables translation between the mouse and human gut microbiotas via functional mapping. Cell Host Microbe 30, 124\u2013138 (2022).","journal-title":"Cell Host Microbe"},{"key":"2484_CR78","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/mbo3.266","volume":"4","author":"M Smati","year":"2015","unstructured":"Smati, M. et al. Quantitative analysis of commensal Escherichia coli populations reveals host-specific enterotypes at the intra-species level. MicrobiologyOpen 4, 604\u2013615 (2015).","journal-title":"MicrobiologyOpen"},{"key":"2484_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04059-1","volume":"9","author":"E Wistrand-Yuen","year":"2018","unstructured":"Wistrand-Yuen, E. et al. Evolution of high-level resistance during low-level antibiotic exposure. Nat. Commun. 9, 1599 (2018).","journal-title":"Nat. Commun."},{"key":"2484_CR80","doi-asserted-by":"publisher","first-page":"1.17.1","DOI":"10.1002\/0471142727.mb0117s79","volume":"79","author":"LC Thomason","year":"2007","unstructured":"Thomason, L. C., Costantino, N. & Court, D. L. Genome manipulation by P1 transduction. Curr. Protoc. Mol. Biol. 79, 1.17.1\u20131.17.8 (2007).","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"2484_CR81","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1128\/jb.174.11.3834-3835.1992","volume":"174","author":"DF Lindsey","year":"1992","unstructured":"Lindsey, D. F., Mart\u00ednez, C. & Walker, J. R. Physical map location of the Escherichia coli attachment site for the P22 prophage (attP22). J. Bacteriol. 174, 3834\u20133835 (1992).","journal-title":"J. Bacteriol."},{"key":"2484_CR82","doi-asserted-by":"publisher","unstructured":"Bataglioli, R. A. et al. Prophage-encoding engineered bacteria enable prophylatic lytic phage therapy for enteric infection in mice (dataset). Zenodo https:\/\/doi.org\/10.5281\/zenodo.20753658 (2026).","DOI":"10.5281\/zenodo.20753658"}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-026-02484-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-026-02484-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-026-02484-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:03:03Z","timestamp":1789549383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-026-02484-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":82,"alternative-id":["2484"],"URL":"https:\/\/doi.org\/10.1038\/s41564-026-02484-3","relation":{},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: R.A.B., H.B. and B.B.H. are inventors on a filed patent application related to the use of the engineered lyto-lysogen to deliver phages and prevent enteric pathogen infections. B.B.H. is a cofounder and equity holder of Lytic Biotechnologies, a company developing phage-based technologies. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}